{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:21:37Z","timestamp":1758817297153},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11882-005-0066-0","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T01:24:15Z","timestamp":1180833855000},"page":"270-276","source":"Crossref","is-referenced-by-count":13,"title":["Basophils and mast cells in chronic idiopathic urticaria"],"prefix":"10.1007","volume":"5","author":[{"given":"Becky M.","family":"Vonakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"66_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","volume":"114","author":"AP Kaplan","year":"2004","unstructured":"Kaplan AP: Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004, 114:465\u2013474; quiz 75. Excellent review of current clinical treatments and autoantibody theory in CIU.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJMcp011186","volume":"346","author":"AP Kaplan","year":"2002","unstructured":"Kaplan AP: Clinical practice: chronic urticaria and angioedema. N Engl J Med 2002, 346:175\u2013179.","journal-title":"N Engl J Med"},{"key":"66_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","volume":"59","author":"E Toubi","year":"2004","unstructured":"Toubi E, Kessel A, Avshovich N, et al.: Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004, 59:869\u2013873. Prospective study of clinical features in CIU related to disease duration.","journal-title":"Allergy"},{"key":"66_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0190-9622(03)00846-6","volume":"49","author":"DG Federman","year":"2003","unstructured":"Federman DG, Kirsner RS, Moriarty JP, Concato J: The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003, 49:861\u2013864.","journal-title":"J Am Acad Dermatol"},{"key":"66_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00130832-200410000-00010","volume":"4","author":"B Wedi","year":"2004","unstructured":"Wedi B, Raap U, Kapp A: Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004, 4:387\u2013396.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"66_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","volume":"143","author":"CE Grattan","year":"2000","unstructured":"Grattan CE, O\u2019Donnell BF, Francis DM, et al.: Randomized double-blind study of cyclosporin in chronic \"idiopathic\" urticaria. Br J Dermatol 2000, 143:365\u2013372.","journal-title":"Br J Dermatol"},{"key":"66_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","volume":"114","author":"L Beck","year":"2004","unstructured":"Beck L, Marcotte G, MacGlashan J, et al.: Omalizumab induced reductions in mast cell FceRI expression and function. J Allergy Clin Immunol 2004, 114:527\u2013530.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","volume":"99","author":"LJ Tong","year":"1997","unstructured":"Tong LJ, Balakrishnan G, Kochan JP, et al.: Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997, 99:461\u2013465.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","volume":"101","author":"M Ferrer","year":"1998","unstructured":"Ferrer M, Kinet JP, Kaplan AP: Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998, 101:672\u2013676.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","volume":"90","author":"BL Gruber","year":"1988","unstructured":"Gruber BL, Baeza ML, Marchese MJ, et al.: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213\u2013217.","journal-title":"J Invest Dermatol"},{"key":"66_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis DM, Grattan CE, et al.: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599\u20131604.","journal-title":"N Engl J Med"},{"key":"66_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/0140-6736(92)90666-Q","volume":"339","author":"CE Grattan","year":"1992","unstructured":"Grattan CE, Francis DM, Slater NG, et al.: Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992, 339:1078\u20131080.","journal-title":"Lancet"},{"key":"66_CR13","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1067\/mai.2001.115484","volume":"107","author":"Y Kikuchi","year":"2001","unstructured":"Kikuchi Y, Kaplan AP: Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001, 107:1056\u20131062.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1067\/mai.2002.120954","volume":"109","author":"Y Kikuchi","year":"2002","unstructured":"Kikuchi Y, Kaplan AP: A role for C5a in augmenting IgGdependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002, 109:114\u2013118.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","volume":"106","author":"N Niimi","year":"1996","unstructured":"Niimi N, Francis DM, Kermani F, et al.: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001\u20131006.","journal-title":"J Invest Dermatol"},{"key":"66_CR16","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.131.4.1936","volume":"131","author":"ES Schulman","year":"1983","unstructured":"Schulman ES, Kagey-Sobotka A, MacGlashan DW Jr, et al.: Heterogeneity of human mast cells. J Immunol 1983, 131:1936\u20131941.","journal-title":"J Immunol"},{"key":"66_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1067\/mai.2002.126782","volume":"110","author":"RA Sabroe","year":"2002","unstructured":"Sabroe RA, Fiebiger E, Francis DM, et al.: Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002, 110:492\u2013499. Insight into relationship between serologic factors and CIU disease severity.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR18","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1067\/mai.2001.114653","volume":"107","author":"SS Saini","year":"2001","unstructured":"Saini SS, Richardson JJ, Wofsy C, et al.: Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils. J Allergy Clin Immunol 2001, 107:832\u2013841.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","volume":"101","author":"E Fiebiger","year":"1998","unstructured":"Fiebiger E, Hammerschmid F, Stingl G, Maurer D: Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998, 101:243\u2013251.","journal-title":"J Clin Invest"},{"key":"66_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/HAB-2001-103-404","volume":"10","author":"SM Miescher","year":"2001","unstructured":"Miescher SM, Horn MP, Pachlopnik JM, et al.: Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies 2001, 10:119\u2013126.","journal-title":"Hum Antibodies"},{"key":"66_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","volume":"103","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Poon E, Orchard GE, et al.: Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999, 103:484\u2013493.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","volume":"40","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Seed PT, Francis DM, et al.: Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999, 40:443\u2013450.","journal-title":"J Am Acad Dermatol"},{"key":"66_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.0022-202x.2001.00027.x","volume":"6","author":"CE Grattan","year":"2001","unstructured":"Grattan CE: Basophils in chronic urticaria. J Investig Dermatol Symp Proc 2001, 6:139\u2013140.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"66_CR24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","volume":"27","author":"CE Grattan","year":"1997","unstructured":"Grattan CE, Walpole D, Francis DM, et al.: Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997, 27:1417\u20131424.","journal-title":"Clin Exp Allergy"},{"key":"66_CR25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","volume":"57","author":"F Kern","year":"1976","unstructured":"Kern F, Lichtenstein LM: Defective histamine release in chronic urticaria. J Clin Invest 1976, 57:1369\u20131377.","journal-title":"J Clin Invest"},{"key":"66_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","volume":"33","author":"CE Grattan","year":"2003","unstructured":"Grattan CE, Dawn G, Gibbs S, Francis DM: Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003, 33:337\u2013341.","journal-title":"Clin Exp Allergy"},{"key":"66_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","volume":"102","author":"RA Sabroe","year":"1998","unstructured":"Sabroe RA, Francis DM, Barr RM, et al.: Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998, 102:651\u2013658.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR28","first-page":"893","volume-title":"Allergy Principles and Practice","author":"RP Schleimer","year":"1993","unstructured":"Schleimer RP: Glucocorticosteroids: their mechanism of action and use in allergic diseases. In Allergy Principles and Practice, edn 4. Edited by Middleton E, Reed CE, Ellis EF, et al. St. Louis, MO: Mosby; 1993:893\u2013925.","edition":"edn 4"},{"key":"66_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.146.2.671","volume":"146","author":"EN Charlesworth","year":"1991","unstructured":"Charlesworth EN, Kagey-Sobotka A, Schleimer RP, et al.: Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991, 146:671\u2013676.","journal-title":"J Immunol"},{"key":"66_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1067\/mai.2001.116575","volume":"108","author":"C Yoshimura","year":"2001","unstructured":"Yoshimura C, Miyamasu M, Nagase H, et al.: Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 2001, 108:215\u2013220.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1067\/mai.2002.123236","volume":"109","author":"S Ying","year":"2002","unstructured":"Ying S, Kikuchi Y, Meng Q, et al.: TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002, 109:694\u2013700. Recent study defining characteristics of cellular infiltrate in CIU.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1034\/j.1600-0625.2003.00010.x","volume":"12","author":"M Caproni","year":"2003","unstructured":"Caproni M, Volpi W, Macchia D, et al.: Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp Dermatol 2003, 12:621\u2013628.","journal-title":"Exp Dermatol"},{"key":"66_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0091-6749(95)70055-2","volume":"96","author":"CH Smith","year":"1995","unstructured":"Smith CH, Kepley C, Schwartz LB, Lee TH: Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995, 96:360\u2013364.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.clim.2004.10.007","volume":"114","author":"M Caproni","year":"2005","unstructured":"Caproni M, Giomi B, Volpi W, et al.: Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin Immunol 2005, 114:284\u2013292.","journal-title":"Clin Immunol"},{"key":"66_CR35","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI118337","volume":"96","author":"LB Schwartz","year":"1995","unstructured":"Schwartz LB, Sakai K, Bradford TR, et al.: The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995, 96:2702\u20132710.","journal-title":"J Clin Invest"},{"key":"66_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1081-1206(10)62063-7","volume":"91","author":"R Asero","year":"2003","unstructured":"Asero R, Tedeschi A, Lorini M, et al.: Circulating stem cell factor in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2003, 91:79\u201381.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"66_CR37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1056\/NEJM198110293051808","volume":"305","author":"AP Kaplan","year":"1981","unstructured":"Kaplan AP, Garofalo J, Sigler R, Hauber T: Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med 1981, 305:1074\u20131077.","journal-title":"N Engl J Med"},{"key":"66_CR38","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","volume":"83","author":"AA Irani","year":"1986","unstructured":"Irani AA, Schechter NM, Craig SS, et al.: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 1986, 83:4464\u20134468.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"66_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0091-6749(92)90297-F","volume":"89","author":"P Jacques","year":"1992","unstructured":"Jacques P, Lavoie A, Bedard PM, et al.: Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 1992, 89:1139\u20131143.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008480-200308000-00008","volume":"15","author":"DY Leung","year":"2003","unstructured":"Leung DY: Infection in atopic dermatitis. Curr Opin Pediatr 2003, 15:399\u2013404.","journal-title":"Curr Opin Pediatr"},{"key":"66_CR41","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1172\/JCI200214704","volume":"109","author":"V Supajatura","year":"2002","unstructured":"Supajatura V, Ushio H, Nakao A, et al.: Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002, 109:1351\u20131359.","journal-title":"J Clin Invest"},{"key":"66_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000073709","volume":"132","author":"JS Marshall","year":"2003","unstructured":"Marshall JS, McCurdy JD, Olynych T: Toll-like receptor-mediated activation of mast cells: implications for allergic disease? Int Arch Allergy Immunol 2003, 132:87\u201397.","journal-title":"Int Arch Allergy Immunol"},{"key":"66_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/eji.200323830","volume":"33","author":"S Varadaradjalou","year":"2003","unstructured":"Varadaradjalou S, Feger F, Thieblemont N, et al.: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003, 33:899\u2013906.","journal-title":"Eur J Immunol"},{"key":"66_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000077213","volume":"133","author":"C Tkaczyk","year":"2004","unstructured":"Tkaczyk C, Okayama Y, Metcalfe DD, Gilfillan AM: Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release. Int Arch Allergy Immunol 2004, 133:305\u2013315.","journal-title":"Int Arch Allergy Immunol"},{"key":"66_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.it.2004.03.005","volume":"25","author":"U Blank","year":"2004","unstructured":"Blank U, Rivera J: The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 2004, 25:266\u2013273.","journal-title":"Trends Immunol"},{"key":"66_CR46","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4049\/jimmunol.118.4.1317","volume":"118","author":"MC Conroy","year":"1977","unstructured":"Conroy MC, Adkinson NF Jr, Lichtenstein LM: Measurement of IgE on human basophils: relation to serum IgE and anti-IgEinduced histamine release. J Immunol 1977, 118:1317\u20131321.","journal-title":"J Immunol"},{"key":"66_CR47","first-page":"53","volume":"122","author":"SR Findlay","year":"1980","unstructured":"Findlay SR, Lichtenstein LM: Basophil releasability in patients with asthma. Am Rev Respir Dis 1980, 122:53\u201359.","journal-title":"Am Rev Respir Dis"},{"key":"66_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0091-6749(99)70367-2","volume":"104","author":"CL Kepley","year":"1999","unstructured":"Kepley CL, Youssef L, Andrews RP, et al.: Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999, 104:279\u2013284.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/ajrcmb.23.4.4123","volume":"23","author":"S Lavens-Phillip","year":"2000","unstructured":"Lavens-Phillip S, MacGlashan D: The tyrosine kinases, p53 lyn, p72 syk are differentially expressed at the protein level, not the mRNA level in non-releasing human basophils. Am J Cell Respir Mol Med 2000, 23:566\u2013571.","journal-title":"Am J Cell Respir Mol Med"},{"key":"66_CR50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1067\/mai.2003.1671","volume":"112","author":"CL Kepley","year":"2003","unstructured":"Kepley CL, Cohen N: Evidence for human mast cell nonreleaser phenotype. J Allergy Clin Immunol 2003, 112:457\u2013459.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR51","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1073\/pnas.95.19.11330","volume":"95","author":"M Huber","year":"1998","unstructured":"Huber M, Helgason CD, Damen JE, et al.: The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A 1998, 95:11330\u201311335.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"66_CR52","first-page":"68","volume":"25","author":"MJ Rauh","year":"2002","unstructured":"Rauh MJ, Krystal G: Of mice and men: elucidating the role of SH2-containing inositol 5-phosphatase (SHIP) in human disease. Clin Invest Med 2002, 25:68\u201370. Excellent review of the clinical implications of SHIP phosphatase activity in human disease.","journal-title":"Clin Invest Med"},{"key":"66_CR53","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.7542803","volume":"269","author":"SM MacDonald","year":"1995","unstructured":"MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995, 269:688\u2013690.","journal-title":"Science"},{"key":"66_CR54","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1067\/mai.2001.119159","volume":"108","author":"BM Vonakis","year":"2001","unstructured":"Vonakis BM, Gibbons S Jr, Sora R, et al.: Src homology 2 domain-containing inositol 5\u2019 phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 2001, 108:822\u2013831.","journal-title":"J Allergy Clin Immunol"},{"key":"66_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/35051094","volume":"409","author":"S Clement","year":"2001","unstructured":"Clement S, Krause U, Desmedt F, et al.: The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 2001, 409:92\u201397.","journal-title":"Nature"},{"key":"66_CR56","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2337\/diabetes.51.7.2012","volume":"51","author":"E Marion","year":"2002","unstructured":"Marion E, Kaisaki PJ, Pouillon V, et al.: The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 2002, 51:2012\u20132017.","journal-title":"Diabetes"},{"key":"66_CR57","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/S0091-6749(03)80602-4","volume":"111","author":"SS Saini","year":"2003","unstructured":"Saini SS, Vasagar K, Huang F, et al.: Signaling defects in basophils in chronic urticaria. J Allergy Clin Immunol 2003, 111:S178.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-005-0066-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0066-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:05:20Z","timestamp":1707937520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-005-0066-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11882-005-0066-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}